ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

NCI appoints Robert Young chairman of the Board of Scientific Advisors, reappoints Ellen Sigal, and names 11 new members to board. Earnest Hawk to direct NCI Office of Centers, Training and Resources.

November 12, 2004

DCT Board Okays Concepts For New Trials In Imaging, Intraoperative RT

June 14, 1985

Partial Responses To Zactima In Thyroid Cancer Trial

January 27, 2006

Time Spent Sitting Associated With Total Mortality, Study Finds

July 30, 2010

In Brief: Beahrs Headed Team For President’s Surgery; Chiles Chairs HHS Appropriations Subcommittee

January 9, 1987

NCI, DOE Working Out Details Of Converting Portion Of Idaho Facility to Work On BNCT

July 1, 1988